<--- Back to Details
First PageDocument Content
Endocrine system / Peptides / Lung cancer / Gastrointestinal cancer / Neuroendocrine tumor / Carcinoid / Insulinoma / Somatostatin / Octreotide / Medicine / Oncology / Neuroendocrinology
Date: 2012-06-18 21:28:45
Endocrine system
Peptides
Lung cancer
Gastrointestinal cancer
Neuroendocrine tumor
Carcinoid
Insulinoma
Somatostatin
Octreotide
Medicine
Oncology
Neuroendocrinology

Add to Reading List

Source URL: www.carcinoid.org

Download Document from Source Website

File Size: 107,17 KB

Share Document on Facebook

Similar Documents

PDF Document

DocID: 1xrdj - View Document

Endocrine system / Clinical medicine / Medicine / Cyclic peptides / Neuroendocrinology / Octreotide / Opioids / Neuroendocrine tumor / Acromegaly / Carcinoid syndrome / Nitrazepam / Lanreotide

ORIGINAL ARTICLE Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients Eugene A. Woltering, MD, FACS,* Vergilio A. Salvo, MD,* Thomas M. O_D

DocID: 1rlNJ - View Document

Clinical medicine / Cancer / Endocrine system / Neuroendocrinology / Octreotide / Opioids / Renal physiology / Neuroendocrine tumor / Carcinoid syndrome / Creatinine / Perphenazine

JOBNAME: pan 31#PAGE: 1 OUTPUT: Wednesday October 19 08:24:lww/panMPA200087 ORIGINAL ARTICLE Effect of Octreotide LAR Dose and Weight on Octreotide

DocID: 1qMJM - View Document

Neuroendocrinology / Cyclic peptides / Hydroxyarenes / Pancreatic cancer / Neuroendocrine tumor / Carcinoid / Octreotide / 5-Hydroxyindoleacetic acid / Chromogranin A / Pheochromocytoma / Lanreotide / Serotonin

ORIGINAL ARTICLE Validation of Serum Versus Plasma Measurements of Chromogranin A Levels in Patients With Carcinoid Tumors Lack of Correlation Between Absolute Chromogranin A Levels and Symptom Frequency

DocID: 1p1DF - View Document

Proteins / Chromogranin A / Laboratory techniques / 5-Hydroxyindoleacetic acid / Neuroendocrine tumor / Granin / Assay / Carcinoid / Biomarker

ORIGINAL ARTICLE Development of a Highly Sensitive and Specific Carboxy-Terminal Human Pancreastatin Assay to Monitor Neuroendocrine Tumor Behavior Thomas M. O’Dorisio, MD,* Siegfried R. Krutzik, PhD,Þ Eugene A. Wolt

DocID: 1oIE2 - View Document